(GDOC) Goldman Sachs Trust - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US38149W7700 • Health
GDOC: Equity, Stocks, Health, Medicine, Genomics, Precision, Technology
The fund invests, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes (measured at the time of purchase) in equity investments in U.S. and non-U.S. health care companies. The adviser generally intends to invest in companies that the adviser believes are aligned with key themes associated with innovation in health care, which include, but are not limited to, genomics, precision medicine, technology-enabled procedures, and digital healthcare. The fund is non-diversified.
Additional Sources for GDOC ETF
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
GDOC ETF Overview
| Market Cap in USD | 20m |
| Category | Health |
| TER | 0.75% |
| IPO / Inception | 2021-11-09 |
GDOC ETF Ratings
| Growth 5y | -12.2% |
| Fundamental | - |
| Dividend | 6.05% |
| Rel. Strength Industry | -93.5 |
| Analysts | - |
| Fair Price Momentum | 28.60 USD |
| Fair Price DCF | - |
GDOC Dividends
| Dividend Yield 12m | 0.02% |
| Yield on Cost 5y | 0.02% |
| Annual Growth 5y | -81.69% |
| Payout Consistency | 50.8% |
GDOC Growth Ratios
| Growth Correlation 3m | -73.8% |
| Growth Correlation 12m | 4% |
| Growth Correlation 5y | 38.1% |
| CAGR 5y | -4.96% |
| CAGR/Mean DD 5y | -0.30 |
| Sharpe Ratio 12m | -0.12 |
| Alpha | -22.80 |
| Beta | 0.91 |
| Volatility | 14.99% |
| Current Volume | 0.3k |
| Average Volume 20d | 2.3k |
What is the price of GDOC stocks?
As of January 23, 2025, the stock is trading at USD 33.53 with a total of 300 shares traded.
Over the past week, the price has changed by +2.13%, over one month by +2.82%, over three months by -4.92% and over the past year by +1.75%.
As of January 23, 2025, the stock is trading at USD 33.53 with a total of 300 shares traded.
Over the past week, the price has changed by +2.13%, over one month by +2.82%, over three months by -4.92% and over the past year by +1.75%.
Is Goldman Sachs Trust a good stock to buy?
Neither. Based on ValueRay Analyses, Goldman Sachs Trust is currently (January 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -12.21 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of GDOC as of January 2025 is 28.60. This means that GDOC is currently overvalued and has a potential downside of -14.7%.
Neither. Based on ValueRay Analyses, Goldman Sachs Trust is currently (January 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -12.21 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of GDOC as of January 2025 is 28.60. This means that GDOC is currently overvalued and has a potential downside of -14.7%.
Is GDOC a buy, sell or hold?
Goldman Sachs Trust has no consensus analysts rating.
Goldman Sachs Trust has no consensus analysts rating.
What are the forecast for GDOC stock price target?
According to ValueRays Forecast Model, GDOC Goldman Sachs Trust will be worth about 31.7 in January 2026. The stock is currently trading at 33.53. This means that the stock has a potential downside of -5.43%.
According to ValueRays Forecast Model, GDOC Goldman Sachs Trust will be worth about 31.7 in January 2026. The stock is currently trading at 33.53. This means that the stock has a potential downside of -5.43%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 31.7 | -5.4% |